Distinguished Professor

chencj
886-2-27871302

EDUCATION AND POSITIONS HELD:

• Sc.D., Department of Epidemiology, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland, USA, 1982
• Associate Professor, Graduate Institute of Public Health, National Taiwan University College of Medicine, Taiwan, 1983-1986
• Professor, Graduate Institute of Public Health, National Taiwan University College of Medicine, Taiwan, 1986-1993
• Director, Graduate Institute of Public Health, National Taiwan University College of Public Health, Taiwan, 1993-1994
• Professor, Graduate Institute of Epidemiology, National Taiwan University College of Public Health, Taiwan, 1994-2006
• Founding Director, Graduate Institute of Epidemiology, National Taiwan University College of Public Health, Taiwan, 1994-1997
• Director General, Division of Life Sciences, National Science Council, Taiwan, 1997-1999
• Dean, College of Public Health, National Taiwan University, Taiwan, 1999-2002
• Deputy Minister, National Science Council, Taiwan, 2002-2003
• Minister, Department of Health, Taiwan, 2003-2005
• Distinguished Professor, Genomics Research Center, Academia Sinica, Taiwan, 2006-2015, 2020-now
• Minister, National Science Council, Taiwan, 2006-2008
• Vice President, Academia Sinica, Taiwan, 2011-2015
• Vice President, Office of President, Taiwan, 2016-2020
• Premier, Executive Yuan, Taiwan, 2023-2024

HONORS:

• Outstanding Research Fellow Award, National Science Council, Taiwan, 1986-1996
• Fogarty International Research Fellowship, US National Institute of Health, USA, 1989
• Outstanding Teaching Award, Ministry of Education, Taiwan, 1992
• Outstanding Scholar, Foundation for Outstanding Scholarship, Taiwan, 1995-1999
• National Chair Professor, Ministry of Education, Taiwan, 1997-2002
• Academic Award, Ministry of Education, Taiwan, 1997
• Academician, Academia Sinica, Taiwan, 1998
• ISI Citation Classic Award, ISI Thomas Scientific, USA, 2001
• Outstanding Research Fellow Award, National Science Council, Taiwan, 2003
• Health Medal (First Rank), Department of Health, Taiwan, 2005
• Achievement Medal (First Rank), Executive Yuan, Taiwan, 2005
• Presidential Science Prize, Office of the President, Taiwan, 2005
• Member, World Academy of Sciences, Italy, 2005
• Honorary Member, Mongolian Academy of Sciences, Mongolia, 2007
• Cutter Lecturer on Preventive Medicine, Harvard University, USA, 2008
• Dr. DV Datta Memorial Oration, National Association for the Study of the Liver, India, 2008
• Officier dans l’Ordre des Palmes Academiques, Ministry of Education, France, 2009
• Science and Engineering Achievement Award, Taiwanese-American Foundation, USA, 2009
• Member, Delta Omega Honorary Society in Public Health, Johns Hopkins University, USA, 2010
• Outstanding Merit Award, Wang Ming-Ning Memorial Foundation, Taiwan, 2010
• Knight, Equestrian Order of the Holy Sepulcher of Jerusalem, Vatican, 2010
• Excellence in Cancer Prevention Award, Taiwan Joint Cancer Conference, Taiwan, 2011
• Prof. Vikit Viranuvatti Lecturer, Gastroenterological Association of Thailand, Thailand, 2011
• Science Profession Medal (First Rank), National Science Council, Taiwan, 2012
• Knowledge for the World Award, Johns Hopkins University, USA, 2012
• Knight, Pontifical Equestrian Order of St. Gregory the Great, Vatican, 2013
• Outstanding Achievement Award in Science and Technology, Executive Yuan, Taiwan, 2013
• Prof. Juei-Low Sung Award, Asia-Pacific Primary Liver Cancer Expert Meeting, Taiwan, 2014
• Honorary Doctor of Philosophy, China Medical University, Taiwan, 2014
• Distinguished Service Medal (First Class), Academia Sinica, Taiwan, 2016
• International Member, National Academy of Sciences, USA, 2017
• Honorary Doctor of Philosophy, Kaohsiung Medical University, Taiwan, 2020
• Honorary Doctor of Science, National Sun Yet-Sen University, Taiwan, 2020
• Order of Dr. Sun Yat-sen with Grand Cordon, Office of the President, Taiwan, 2020
• Academician, Pontifical Academy of Sciences, Vatican, 2021
• Order of Propitious Clouds with Special Grand Cordon, Office of the President, Taiwan, 2024

RESEARCH INTERESTS:

Molecular and genomic epidemiology

Researches in the Chen’s lab encompass a broad spectrum of molecular and genomic epidemiology. They include:

SELECTED PUBLICATIONS:

• G. A. Kim, Y. S. Lim*, S. Han, G. H. Choi, W. M. Choi, J. Choi, D. H. Sinn, Y. H. Paik, J. H. Lee, Y. B. Lee, J. Y. Cho, N. Y. Heo, M. F. Yuen, V. W. Wong, S. L. Chan, H. I. Yang and C. J. Chen, 2024, “Viral load-based prediction of hepatocellular carcinoma risk in non-cirrhotic chronic hepatitis B patients: a multinational study for the development and external validation of a new prognostic model”, Ann Intern Med, 177(10), 1308-1318.
• J. R. Jhuang, C. H. Lee, C. J. Chiang, C. J. Chen and W. C. Lee*, 2024, “Reduced burden of arsenic-related cancers after water mitigation in Taiwan”, Environ Int, 185, 108542.
• G. C. Chang, C. H. Chiu, C. J. Yu, Y. C. Chang, Y. H. Chang, K. H. Hsu, Y. C. Wu, C. Y. Chen, H. H. Hsu, M. T. Wu, C. T. Yang, I. W. Chong, Y. C. Lin, T. C. Hsia, M. C. Lin, W. C. Su, C. B. Lin, K. Y. Lee, Y. F. Wei, G. Y. Lan, W. P. Chan, K. L. Wang, M. H. Wu, H. H. Tsai, C. F. Chian, R. S. Lai, J. Y. Shih, C. L. Wang, J. S. Hsu, K. C. Chen, C. K. Chen, J. Y. Hsia, C. K. Peng, E. K. Tang, C. L. Hsu, T. Y. Chou, W. C. Shen, Y. H. Tsai, C. M. Tsai, Y. M. Chen, Y. C. Lee, H. Y. Chen, S. L. Yu, C. J. Chen, Y. L. Wan, C. A. Hsiung, P. C. Yang* and TALENT Investigators, 2024, “Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study”, Lancet Respir Med, 12(2), 41-152.
• W. K. J. Lam, A. D. King, J. A. Miller, Z. Liu, K. J. Yu, M. L. K. Chua, B. B. Y. Ma, M. Y. Chen, B. A. Pinsky, P. J. Lou, J. K. S. Woo, W. L. Hsu, J. Simon, D. L. Doolan, T. Waterboer, E. P. Hui, H. Li, R. K. Tsang, K. C. W. Wong, J. P. Goh, A. C. Vlantis, Q. Y. Ai, L. M. Wong, V. Abdullah, J. C. Lin, C. J. Chen, R. M. Pfeiffer, Q. T. Le, A. W. M. Lee, M. Ji, S. Cao, J. Ma, A. T. C. Chan, K. C. A. Chan* and A. Hildesheim, 2023, “Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions”, J Natl Cancer Inst, 115(4), 355–364.
• P. J. Lou, W. K. J. Lam, W. L. Hsu, R. M. Pfeiffer, K. J. Yu, C. M. L. Chan, V. C. T. Lee, T. C. Chen, S. D. Terng, Y. A. Tsou, Y. S. Leu, L. J. Liao, Y. L. Chang, Y. C. Chien, C. P. Wang, C. Y. Lin, C. H. Hua, J. C. Lee, T. L. Yang, C. H. Hsiao, M. S. Wu, M. H. Tsai, H. C. Cheng, A. Hildesheim, C. J. Chen, K. C. A. Chan*, Z. Liu and GEV-NPC Study Group, 2023, “Performance and Operational Feasibility of Epstein-Barr Virus-Based Screening for Detection of Nasopharyngeal Carcinoma: Direct Comparison of Two Alternative Approaches”, J Clin Oncol, 41(26), 4257-4266.
• C. J. Chen*, 2022, “Taiwan’s pandemic vice-president: from lab bench to public office and back”, Nature, 603(7900), 203.
• C. J. Chiang, J. R. Jhuang, Y. W. Yang, B. Z. Zhuang, S. L. You, W. C. Lee and C. J. Chen*, 2022, “Association of nationwide hepatitis B vaccination and antiviral therapy programs with end-stage liver disease burden in Taiwan”, JAMA Network Open, 5(7), e2222367. (SCIE)
• C. J. Chen*, S. L. You, W. L. Hsu, H. I. Yang, M. H. Lee, H. C. Chen, Y. Y. Chen, J. Liu, H. H. Hu, Y. J. Lin, Y. J. Chu, Y. T. Huang, C. J. Chiang and Y. C. Chien, 2021, “Epidemiology of virus infection and human cancer”, Recent Results Cancer Res, 217, 13-45.
• C. J. Chen*, 2021, “The strategy behind Taiwan’s COVID-19 immunization program: national security and global solidarity”, Taiwan Strategists, 11, 1-18.
• G. Awandare*, E. André*, E. Corrales-Aguilar*, C. J. Chen*, M. A. Mostajo-Radji*, L. Jancoriene* and M. Nemer, 2020, “Science advisers around the world on 2020”, Nature, 588(7839), 586-588.
• W. L. Hsu, Y. C. Chien, Y. T. Huang, K. J. Yu, J. Y. Ko, C. Y. Lin, Y. A. Tsou, Y. S. Leu, L. J. Liao, Y. L. Chang, J. Y. Su, Z. Liu, C. P. Wang, S. D. Terng, C. H. Hua, J. C. Lee, T. L. Yang, C. H. K. Hsiao, M. S. Wu, M. H. Tsai, M. J. Liu, P. J. Lou, A. Hildesheim and C. J. Chen*, 2020, “Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis.”, Cancer Medicine, 9(5), 1867-1876. (SCIE)
• M. H. Lee, H. I. Yang, S. N. Lu, C. L. Jen, S. L. You, L. Y. Wang, C. H. Wang, W. J. Chen, C. J. Chen* and REVEAL-HCV Study Group, 2012, “Chronic hepatitis C virus infection increase mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study”, J Infect Dis, 206, 469-477.
• H. I. Yang, M. F. Yuen, H. L. Chan, K. H. Han, P. J. Chen, D. Y. Kim, S. H. Ahn, C. J. Chen*, V. W. Wong and W. K. Seto, 2011, “Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score”, Lancet Oncol, 12, 568-574.
• H. C. Chen, M. Schiffman, C. Y. Lin, M. H. Pan, S. L. You, L. C. Chuang, C. Y. Hsieh, K. L. Liaw, A. W. Hsing, C. J. Chen* and CBCSP-HPV Study Group, 2011, “Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer”, J Natl Cancer Inst, 103, 1387-1396.
• H. I. Yang, S. H. Yeh, P. J. Chen, U. H. Iloeje, C. L. Jen, L. Y. Wang, S. N. Lu, S. L. You, D. S. Chen, Y. F. Liaw, C. J. Chen* and REVEAL-HBV Group, 2008, “Association between Hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma”, J Natl Cancer I, 100, 1134-1143.
• C. L. Chen, H. I. Yang, W. S. Yang, C. J. Liu, P. J. Chen, S. L. You, L. Y. Wang, C. A. Sun, S. N. Lu, D. S. Chen and C. J. Chen*, 2008, “Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C virus infection: a follow-up study in Taiwan”, Gastroenterology, 135, 111-121. (SCIE)
• U. H. Iloeje, H. I. Yang, J. Su, C. L. Jen, S. L. You and C. J. Chen*, 2006, “Predicting cirrhosis risk based on the level of circulating hepatitis B viral load”, Gastroenterology, 130, 678-686. (SCIE)
• C. J. Chen*, H. I. Yang, J. Su, C. L. Jen, S. L. You, S. N. Lu, G. T. Huang and U. H. Iloeje, 2006, “Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level”, JAMA, 295, 65-73.
• H. I. Yang, S. N. Lu, S. L. You, C. A. Sun, L. Y. Wang, K. Hsiao, P. J. Chen, D. S. Chen, Y. F. Liaw and C. J. Chen*, 2002, “Hepatitis B e antigens and the risk of hepatocellular carcinoma”, New Engl J Med, 347, 168-174. (SCIE)
• Y. C. Chien, J. Y. Chen, M. Y. Liu, H. I. Yang, M. M. Hsu, C. J. Chen* and C. S. Yang, 2001, “Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men”, New Engl J Med, 345, 1877-1882. (SCIE)
• K. H. Morales, L. Ryan*, T. L. Kuo, M. M. Wu and C. J. Chen, 2000, “Risk of internal cancers from arsenic in drinking water”, Environ Health Perspect, 108, 655-661. (SCIE)
• C. J. Chen*, M. W. Yu and Y. F. Liaw, 1997, “Epidemiological characteristics and risk factors of hepatocellular carcinoma”, J Gastroenterol Hepatol, 12, S294-S308.
• M. H. Chang*, C. J. Chen, M. S. Lai, M. S. Kong, T. C. Wu, D. C. Liang, H. M. Hsu, W. Y. Shau, D. S. Chen and Taiwan Childhood Hepatoma Study Group, 1997, “Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children”, New Engl J Med, 336, 1855-1859. (SCIE)
• H. Y. Chiou, Y. M. Hsueh, K. F. Liaw, S. F. Horng, M. H. Chiang, Y. S. Pu, J. S. N. Lin, C. H. Huang and C. J. Chen*, 1995, “Incidence of internal cancers and ingested inorganic arsenic: A seven-year follow-up study in Taiwan”, Cancer Res, 55, 1296-1300. (SCIE)
• C. J. Chen*, Y. M. Hsueh, M. S. Lai, M. P. Hsu, M. M. Wu and T. Y. Tai, 1995, “Increased prevalence of hypertension and long-term arsenic exposure”, Hypertension, 25, 53-60. (SCIE)
• C. J. Chen*, C. W. Chen, M. M. Wu and T. L. Kuo, 1992, “Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water”, Brit J Cancer, 66, 888-892. (SCIE)
• C. J. Chen* and C. J. Wang, 1990, “Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms”, Cancer Res, 50, 5470-5474. (SCIE)
• M. M. Wu, T. L. Kuo, Y. H. Hwang and C. J. Chen*, 1989, “Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases”, Am J Epidemiol, 130, 1123-1132. (SCIE)
• C. J. Chen*, T. L. Kuo and M. M. Wu, 1988, “Arsenic and cancers (letter)”, Lancet, 1, 414-415. (SCIE)
• C. J. Chen*, Y. C. Chuang, T. M. Lin and H. Y. Wu, 1985, “Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: High-arsenic artesian well water and cancers”, Cancer Res, 45, 5895-5899. (SCIE)